PCM
ADMA icon

Prelude Capital Management’s ADMA Biologics ADMA Stock Holding History

Prelude Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-32,308
Closed -$77K – 1226
2020
Q3 		$77K Buy
+32,308
New +$88.6K ﹤0.01% 994
2018
Q4 		– Sell
-47,400
Closed -$294K – 1737
2018
Q3 		$294K Sell
47,400
-11,479
-19% -$66.1K 0.02% 676
2018
Q2 		$266K Buy
58,879
+1,579
+3% +$7.87K 0.02% 696
2018
Q1 		$264K Buy
57,300
+14,924
+35% +$59.3K 0.02% 616
2017
Q4 		$136K Buy
42,376
+3,376
+9% +$9.44K 0.01% 708
2017
Q3 		$120K Buy
39,000
+3,853
+11% +$12.8K 0.01% 824
2017
Q2 		$130K Buy
35,147
+2,451
+7% +$9.84K 0.01% 707
2017
Q1 		$160K Buy
32,696
+2,696
+9% +$13.3K 0.02% 635
2016
Q4 		$154K Buy
30,000
+3,671
+14% +$21.1K 0.02% 674
2016
Q3 		$191K Buy
26,329
+8,229
+45% +$52.2K 0.02% 582
2016
Q2 		$108K Buy
18,100
+4,905
+37% +$34.4K 0.02% 724
2016
Q1 		$107K Buy
13,195
+1,195
+10% +$6.83K 0.01% 745
2015
Q4 		$97K Buy
12,000
+1,000
+9% +$9K 0.02% 822
2015
Q3 		$92K Buy
11,000
+2,600
+31% +$24K 0.01% 864
2015
Q2 		$78K Buy
8,400
+7,400
+740% +$64K 0.01% 980
2015
Q1 		$10K Sell
1,000
-600
-38% -$6.05K ﹤0.01% 1828
2014
Q4 		$18K Buy
+1,600
New +$18.3K ﹤0.01% 1752

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Prelude Capital Management's ADMA Position: Q4 2020 in Review

Prelude Capital Management sold out of ADMA Biologics (ADMA) in Q4 2020, closing a stake of 32,308 shares — an estimated $77K sold.

Prelude Capital Management first reported a position in ADMA in Q4 2014 and held it in 17 quarters. The position peaked at $294K in Q3 2018. 95 funds tracked by Wall St. Rank hold ADMA as of Q4 2020.

  • Prelude Capital Management reported no remaining ADMA Biologics position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 32,308 ADMA Biologics shares in Q4 2020, an estimated $77K.
  • Prelude Capital Management first reported a position in ADMA Biologics in Q4 2014 and held it in 17 quarters.
  • Prelude Capital Management's ADMA Biologics position peaked at $294K in Q3 2018.
  • 95 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.